The third annual Discover Brigham (and sixth annual iteration of the flagship BRI fall event, previously known as Research Day) took place on Thursday, November 9th. This event brings together our community with the broader Boston healthcare ecosystem to educate and inspire collaboration around innovative science, technology, and medicine.

New this year, the BRI hosted a “demo day” portion of the event that was intended to be an interactive experience to compliment other activities highlighting research across the hospital. Participants of the “demo day” provided an interactive experience for attendees, which included a Zebrafish Display, a Virtual Reality Simulator and as well as the new BEI knowledge Center. More than 800 people pre-registered to attend the event, including industry, media, BWH employees and others from the surrounding Boston community. Eight concurrent thematic scientific sessions highlighted work being done on cutting-edge topics including Artificial Intelligence, Gene-Editing, Immunotherapy, Microbiome, Nursing Research, Population Health, Trauma Research and Wellness & Alternative Medicine. Research was highlighted throughout the hospital with approximately 96 electronic poster boards showcasing work in Cancer, Clinical Research, Nursing, Trauma, Women’s Health, Neurosciences and more.

Recipients of the BRI Director’s Transformative Award (see below), the BRIght Futures Prize (see below) and the Research Excellence Awards were announced.

  • Michael Brenner, MD 
    Professor, Department of Medicine, Division of Rheumatology, Immunology and Allergy
    Disease Deconstruction by Single Cell Transcriptomics
  • Terrie Inder, MD
    Department of Newborn Medicine
    Transformative Award in Newborn Research – A Healthy Start to Life
  • Ellen Bubrick, MD
    Neurologist, Division of Epilepsy
    Break The Shake: Ultrasound Treatment For Epilepsy
  • Generation of Contractile Muscle Fibers and MuSCs from Human Pluripotent Stem Cells
    Ziad Al Tanoury, PhD 
  • Functionally Clustered microRNAs for GBM Reprogramming and Therapy
    Vivek Bhaskaran, PhD 
  • A Monoclonal anti- aP2 Antibody treats type 2 diabetes and Fatty Liver Disease
    Mehmet Furkan Burak, MD 
  • Protein Biomarker Detection Using Single Molecule Arrays for Early Detection of Cancer and Monitoring Response to Therapy
    Limor Cohen 
  • Identification of novel Resolvin Conjugate in Tissue Regeneration 3 (RCTR3) in human tissues stimulates proresolving phagocyte functions
    Xavier de la Rosa, PhD
  • A Genome Wide Association Study (GWAS) Identifies a Novel Susceptibility Locus Related to Risk for Sporadic Lymphangioleiomyomatosis
    Krinio Giannikou, PhD 
  • Engineering the next generation of oncolytic HSV-1 vectors in the treatment of glioblastoma brain tumor
    Korneel Grauwet, PhD 
  • Genetic variation at the coronary artery disease risk locus GUCY1A3 modifies cardiovascular disease prevention effects of aspirin
    Kathryn Hall, PhD, MPH 
  • Neurospectroscopic Signatures of CTE-Related Impairments in Retired NFL Players
    Marcia Sahaya Louis 
  • Radiation induced cytotoxicity towards circulating tumor cells preventing distant metastasis in pancreatic cancer
    Sayeda Yasmin-Karim, MD, PhD